skip to content
Skip Navigation
Suven Life Sciences

Drug Discovery & Development Support Services (DDDSS)

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists.

Read More..

Drug Discovery & Research/Clinical pipeline

Suven discovery research is focused on discovering and developing new chemical entities (NCEs), which are best in class central nervous system therapies for the treatment of a diverse range of disorders.

Read More..

News/Events

  • Suven Life Sciences announces successful completion and topline results of First-in-Human (FIH) Phase-1 clinical study of SUVN-I6107, a Muscarinic M1 Positive Allosteric Modulator (M1-PAM) and its advancement into Phase-2 clinical development.
  • Suven Life Sciences announces three poster presentations on Samelisant (SUVN-G3031), including global Phase-3, AWAKE Narcolepsy Study at the SLEEP-2026 Annual Meeting being held at Baltimore, USA
  • Suven Life Sciences Reports Positive DSMB Safety Review and Interim Analysis from Ongoing Global Phase 3 Study of Masupirdine in Alzheimer's Disease Agitation at 50% study completers – Study to Continue Unchanged
  • Clarification on price movement
  • Clarification on volume movement letter
  • Suven Life Sciences Reaches 76% Enrollment milestone in Global Phase 3 Masupirdine (SUVN-502) Trial for Agitation in Alzheimer’s Dementia
  • Clarification on price Movement
  • BM Outcome 06.03.2026
  • Clarification on price Movement
  • BM outcome 29.01.2026
More >>

Latest Events